ARCHIVES

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

This article is from The Cancer Letter archive.

Vol. 33 No. 29 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

National Cancer Policy Board a Successful Experiment, NCI Says; Funding Extended

May 19, 2000

Bush Keeps Klausner As NCI Director; Senate Confirms Thompson For HHS.

January 26, 2001

In Brief: Job Discrimination Survey Report Not Ready Until Next Month; Saccharin Date Extended

September 17, 1977

NCI Denies GAO Report That Backlog Still Exists, Says Most were Published As Research Results

May 18, 1979

STI-571 Effects Are Lasting Against GI Stromal Tumors

July 26, 2002

Funding Opportunities: CDC Seeks Initiatives For Tobacco Control; NCI RFA Available

May 8, 1998